Using Dried Blood Samples for RSV Antibody Testing
Author Information
Author(s): White Joleen T., Terstappen Jonne, Levi Micha, Radivojevic Andrijana, Noble Robert, Anderson Aparna B., Wise-Blackman Gwendolyn, Dunne Michael W.
Primary Institution: Bill & Melinda Gates Medical Research Institute, Cambridge, MA USA
Hypothesis
Can dried blood microsampling provide comparable data to serum samples for evaluating the pharmacokinetics and immunogenicity of the RSV monoclonal antibody RSM01?
Conclusion
Dried blood samples showed strong correlation with serum samples for measuring RSM01 concentrations and RSV neutralising activity, indicating they are a suitable alternative for clinical trials.
Supporting Evidence
- RSM01 concentrations measured in dried blood correlated strongly with those in serum.
- 96% agreement in anti-drug antibody results between serum and dried blood samples.
- RSV neutralising activity was comparable between dried blood and serum samples.
Takeaway
This study shows that we can use tiny blood samples instead of regular blood draws to test for RSV antibodies, which is easier for babies.
Methodology
The study compared pharmacokinetics, immunogenicity, and virus neutralisation between matched serum and dried blood samples from a Phase 1 trial.
Potential Biases
Potential discrepancies in immunogenicity results due to near-threshold detection limits.
Limitations
The study was conducted in healthy adults, and the results may not directly translate to infants without further validation.
Participant Demographics
Healthy adults aged 18-49 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website